VRTX Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 40 analysts giving stock ratings to Vertex Pharmaceuticals Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
39
Hold
33
Sell
0
Strong Sell
3
Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc. Stock Analysis VRTX

United States Health Care Large Cap
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The company is headquartered in Boston, Massachusetts and currently employs 6,100 full-time employees. The company has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).
Read More

VRTX Chart

United States flagUnited States Health Care Large Cap

Vertex Pharmaceuticals Inc vs S&P 500 Comparative Returns

Analysis of VRTX stock performance compared to the broader market (S&P 500) across multiple timeframes.

YTD Performance
  • Vertex Pharmace... (VRT...) 16.43%
  • S&P 500 5.05%
Vertex Pharmace... Outperformed S&P 500 by 11.38%
1Y Performance
  • Vertex Pharmace... (VRT...) -4.73%
  • S&P 500 13.06%
Vertex Pharmace... Underperformed S&P 500 by 17.79%
3Y Performance
  • Vertex Pharmace... (VRT...) 61.67%
  • S&P 500 62.03%
Vertex Pharmace... Underperformed S&P 500 by 0.36%
5Y Performance
  • Vertex Pharmace... (VRT...) 59.23%
  • S&P 500 99.19%
Vertex Pharmace... Underperformed S&P 500 by 39.96%

Super Investors

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

lock-image

Community-Curated Collections ( With VRTX )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.